Brief: Bioaffinity Technologies Reports Q3 Results, Provides Business Update
Nov 14 (Reuters) - bioAffinity Technologies Inc
BIAF.O :
* BIOAFFINITY TECHNOLOGIES REPORTS THIRD QUARTER 2022
FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
* BIOAFFINITY TECHNOLOGIES INC - QTRLY LOSS PER SHARE $1.10
* BIOAFFINITY TECHNOLOGIES INC - CO ON TRACK TO EXPAND
MARKETING
OUTREACH FOR ITS INITIAL PRODUCT, CYPATH® LUNG, THAT DETECTS
EARLY-STAGE LUNG CANCER
Source text for Eikon: ID:nBw9MyPSKa
Further company coverage: BIAF.O